Analysts Cite Trough Valuation and Limited Catalysts as Essity Price Targets Edge Lower

Key Takeaways

• Strong demand in incontinence, medical, and feminine care products, coupled with innovation and brand investments, supports sustained revenue and margin growth globally.
  
• Focus on sustainability, premiumization, and ongoing cost-efficiency efforts positions Essity to benefit from changing consumer preferences and improved operating leverage.
  
• Structural volume and margin pressures across key segments, rising costs, and increased competition threaten Essity's growth, profitability, and pricing power in core and emerging markets.

Catalysts

Develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally.

• The company continues to benefit from high and growing demand in incontinence and medical products, supported by an aging global population, which is driving stable long-term volume and revenue growth in these strategic categories.
  
• Essity is experiencing strong growth in Feminine Care and Incontinence Retail segments across multiple geographies, leveraging rising healthcare standards and expanding middle class in emerging markets, supporting expectations of international revenue expansion.
  
• Innovations in premium, eco-friendly, and coreless products-along with industry recognition for sustainability-position Essity to capitalize on shifting consumer preference for sustainable and higher-value tissue and hygiene products, which supports both topline growth and margin expansion.
  
• Investment in brand building and marketing, as demonstrated by recent awards and increased A&P spend, is expected to drive greater brand loyalty and premiumization, bolstering future sales and improving net margins.
  
• Ongoing cost-efficiency initiatives (supply chain savings, planned SG&A reductions, digitalization) are set to enhance operating leverage and protect net margins, especially as the company aims to return to higher volume growth in the face of stabilized input costs.

Essity Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Essity's revenue will grow by 2.7% annually over the next 3 years.
• Analysts assume that profit margins will increase from 9.1% today to 9.7% in 3 years time.
• Analysts expect earnings to reach SEK 14.3 billion (and earnings per share of SEK 21.35) by about June 2029, up from SEK 12.5 billion today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.1x on those 2029 earnings, down from 14.4x today. This future PE is lower than the current PE for the GB Household Products industry at 22.4x.
• Analysts expect the number of shares outstanding to decline by 1.31% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 5.34%, as per the Simply Wall St company report.

Risks

• Persistent weak volume growth in key segments, particularly in Health & Medical and Baby Care, combined with limited ability to stimulate volumes in a challenging macroeconomic environment, poses a risk of structurally lower revenue growth than anticipated.
  
• Rising SG&A costs, notably personnel and IT expenses, paired with insufficient volume growth to absorb these increases, have led to margin contraction and may continue to pressure net margins if costs are not adequately controlled.
  
• Ongoing high promotional pressure and aggressive price competition, especially in segments like Baby Care and lower/mid-tier Consumer Tissue, may erode Essity's pricing power and gross margins, particularly if private label and low-cost competitors continue gaining share.
  
• Sustained weakness in Professional Hygiene, exacerbated by structural shifts such as reduced restaurant and hotel traffic in North America and Europe, suggests lasting lower demand for away-from-home products, potentially limiting revenue and operating leverage in that segment.
  
• Exposure to input cost volatility-including raw materials, tariffs (notably on U.S.-to-Canada exports), and distribution expenses-without commensurate ability to fully pass through these costs in all geographies and segments, could constrain earnings and net margin expansion, especially as industry consolidation intensifies pressure from retailers and distributors.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of SEK265.07 for Essity based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of SEK300.0, and the most bearish reporting a price target of just SEK215.0.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be SEK147.9 billion, earnings will come to SEK14.3 billion, and it would be trading on a PE ratio of 14.1x, assuming you use a discount rate of 5.3%.
• Given the current share price of SEK264.7, the analyst price target of SEK265.07 is 0.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.